SHAUN MICKELSEN: Open Payments
NPI 1871945618 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 30 payments from 12 companies in 2025. Trend: 2023 $703 · 2024 $748 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $193 |
| Tris Pharma Inc | 3 | $64 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Neuronetics, Inc. | 1 | $30 |
| SHIELD THERAPEUTICS INC | 1 | $23 |
| Boston Scientific Corporation | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: VRAYLAR, QULIPTA, Dyanavel XR, Auvelity, FANAPT, NEUROSTAR TMS THERAPY SYSTEM, UBRELVY, ACCRUFER.
Industry payments across UT — which companies pay providers there.
